Head-to-head · Cost-Efficiency Index
AlyveRx vs Livv
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
AlyveRx
Shoppers who specifically want a needle-free sublingual GLP-1 option alongside standard injections on the same platform.
Visit AlyveRxLivv
Cost-first shoppers who want a flat price that doesn't rise as the GLP-1 dose is titrated upward.
Visit LivvThe verdict
AlyveRx and Livv tie on the Cost-Efficiency Index at 64/100, so neither wins outright on the numbers. For most shoppers we'd start with AlyveRx (ranked #173, a hair above #178) — Shoppers who specifically want a needle-free sublingual GLP-1 option alongside standard injections on the same platform. But Livv is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs AlyveRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | AlyveRx | Livv |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 64/100 |
| Semaglutide / mo | $183/mo (starting dose, compounded) | $135/mo (all doses, compounded) |
| Tirzepatide / mo | $283/mo (starting dose, compounded) | $199/mo (all doses, compounded) |
| Semaglutide / yr (modeled) | $2,196 | $1,620 |
| Tirzepatide / yr (modeled) | $3,396 | $2,388 |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #173 | #178 |
AlyveRx
64/100Where the value is
- Offers a genuinely needle-free sublingual delivery option (PermeAct) for both semaglutide and tirzepatide, not just injections
- Also carries brand-name Ozempic, Wegovy, and Mounjaro for patients who want an FDA-approved product
- All four price points (injection and drops, both drugs) are published upfront on the homepage before intake
The tradeoffs
- The dataset's previous $249/mo tirzepatide figure is the SUBLINGUAL DROPS price, not the standard injection ($283/mo) — confirm which form a quoted price refers to
- Sublingual PermeAct absorption relies on the company's own proprietary technology claims and is not FDA-reviewed for weight-loss efficacy
Livv
64/100Where the value is
- Dose-independent flat pricing — the site explicitly commits that cost won't rise as the dose is adjusted, which is unusual among compounded-GLP-1 competitors
- One published price bundles consultation, medication, supplies, shipping and follow-ups with 'no hidden fees' language
- LegitScript verified
The tradeoffs
- Not available in all 50 states, and the site does not list which states are excluded
- No compounding pharmacy name or medical director is disclosed anywhere I could find
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.